MIP
GILD icon

Mondrian Investment Partners’s Gilead Sciences GILD Stock Holding History

Mondrian Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,667
Closed -$1.06M – 103
2024
Q3 		$1.06M Buy
12,667
+494
+4% +$37.7K 0.02% 65
2024
Q2 		$926K Buy
12,173
+568
+5% +$37.9K 0.01% 65
2024
Q1 		$850K Buy
11,605
+8,241
+245% +$634K 0.01% 65
2023
Q4 		$273K Buy
3,364
+338
+11% +$26.3K ﹤0.01% 72
2023
Q3 		$227K Hold
3,026
– – ﹤0.01% 71
2023
Q2 		$233K Hold
3,026
– – ﹤0.01% 65
2023
Q1 		$251K Sell
3,026
-674
-18% -$55.8K 0.01% 62
2022
Q4 		$318K Hold
3,700
– – 0.01% 55
2022
Q3 		$228 Buy
3,700
+1,729
+88% +$109K 0.01% 63
2022
Q2 		$122K Hold
1,971
– – ﹤0.01% 68
2022
Q1 		$117K Hold
1,971
– – ﹤0.01% 68
2021
Q4 		$143K Hold
1,971
– – ﹤0.01% 115
2021
Q3 		$138K Hold
1,971
– – ﹤0.01% 110
2021
Q2 		$136K Hold
1,971
– – ﹤0.01% 114
2021
Q1 		$125K Hold
1,971
– – ﹤0.01% 110
2020
Q4 		$115K Buy
1,971
+1,467
+291% +$88.5K ﹤0.01% 101
2020
Q3 		$29K Sell
504
-212,211
-100% -$14.7M ﹤0.01% 104
2020
Q2 		$16.4M Sell
212,715
-349,184
-62% -$26.8M 0.59% 46
2020
Q1 		$42M Sell
561,899
-317,952
-36% -$22M 1.47% 24
2019
Q4 		$57.2M Buy
879,851
+126,344
+17% +$8.23M 1.5% 21
2019
Q3 		$47.8M Sell
753,507
-334,596
-31% -$21.9M 1.54% 25
2019
Q2 		$73.5M Sell
1,088,103
-13,839
-1% -$910K 2.35% 10
2019
Q1 		$71.6M Buy
1,101,942
+169,158
+18% +$11.2M 2.26% 15
2018
Q4 		$58.3M Buy
932,784
+174,615
+23% +$12.2M 2.14% 14
2018
Q3 		$58.5M Sell
758,169
-164,201
-18% -$12.4M 1.83% 20
2018
Q2 		$65.3M Buy
922,370
+81,763
+10% +$5.77M 1.91% 11
2018
Q1 		$60.7M Buy
840,607
+60,626
+8% +$4.82M 1.65% 18
2017
Q4 		$55.9M Buy
779,981
+7,961
+1% +$605K 1.36% 23
2017
Q3 		$62.5M Buy
+772,020
New +$59M 1.59% 17

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mondrian Investment Partners's GILD Position: Q4 2024 in Review

Mondrian Investment Partners sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 12,667 shares — an estimated $1.06M sold.

Mondrian Investment Partners first reported a position in GILD in Q3 2017 and held it in 29 quarters. The position peaked at $73.5M in Q2 2019. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Mondrian Investment Partners reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Mondrian Investment Partners sold 12,667 Gilead Sciences shares in Q4 2024, an estimated $1.06M.
  • Mondrian Investment Partners first reported a position in Gilead Sciences in Q3 2017 and held it in 29 quarters.
  • Mondrian Investment Partners's Gilead Sciences position peaked at $73.5M in Q2 2019.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Mondrian Investment Partners's 13F filing for Q4 2024, filed 10 Feb 2025.